Clinical TrialsBelzutifan-Lenvatinib Improves Progression-Free Survival in Previously Trea... Belzutifan-Lenvatinib Improves Progression-Free Survival in Previously Trea... Read Post »
ResearchOrganoids Are Reshaping Drug Development as Research Moves from Animal Stud... Organoids Are Reshaping Drug Development as Research Moves from Animal Stud... Read Post »
ResearchSafety of Experimental Gene and Cell Therapies Under Scrutiny: What Recent ... Safety of Experimental Gene and Cell Therapies Under Scrutiny: What Recent ... Read Post »
Health Tidings Mergers & AcquisitionsWerewolf Therapeutics and Ambros Therapeutics Merge to Advance Neridronate ... Werewolf Therapeutics and Ambros Therapeutics Merge to Advance Neridronate ... Read Post »
Health TidingsGossamer Secures Up to $250 Million to Advance Seralutinib Toward FDA Revie... Gossamer Secures Up to $250 Million to Advance Seralutinib Toward FDA Revie... Read Post »
Health TidingsMilestone Advances Etripamil into Phase 3 Trial for Acute AFib With Rapid V... Milestone Advances Etripamil into Phase 3 Trial for Acute AFib With Rapid V... Read Post »
Clinical TrialsCefixime Adds No Benefit to Azithromycin in Large Typhoid Trial, Reinforcin... Cefixime Adds No Benefit to Azithromycin in Large Typhoid Trial, Reinforcin... Read Post »
New Drug ApprovalFDA Grants PMA to Implantica’s RefluxStop® for GERD Treatment FDA Grants PMA to Implantica’s RefluxStop® for GERD Treatment Read Post »
Health TidingsNIH Awards $6.5 Million Grant to Advance Phase 3 PP-01 Trial in Cannabis Us... NIH Awards $6.5 Million Grant to Advance Phase 3 PP-01 Trial in Cannabis Us... Read Post »
Clinical TrialsZalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Zalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Read Post »
Clinical TrialsMepolizumab Improves Disease Control and Moves Patients Toward Remission in... Mepolizumab Improves Disease Control and Moves Patients Toward Remission in... Read Post »
Health TidingsRein Therapeutics Receives FDA Fast Track Designation for LTI-03 in Idiopat... Rein Therapeutics Receives FDA Fast Track Designation for LTI-03 in Idiopat... Read Post »
Health Tidings Mergers & AcquisitionsChai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Chai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Read Post »
Clinical TrialsCan Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Can Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Read Post »
Health TidingsNuvation Bio’s Safusidenib Receives FDA Fast Track Designation in IDH1-Mu... Nuvation Bio’s Safusidenib Receives FDA Fast Track Designation in IDH1-Mu... Read Post »
Health Tidings Mergers & AcquisitionsTolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Tolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Read Post »
Health TidingsFDA Details Clinical Evidence Supporting ASCENIV Expansion to Children Aged... FDA Details Clinical Evidence Supporting ASCENIV Expansion to Children Aged... Read Post »
Clinical TrialsPositive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Positive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Read Post »
Clinical TrialsLeads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Leads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Read Post »
GenericsGlenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal Spray Glenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal Spray Read Post »
New Drug ApprovalUltragenyx’s GENGLYCOS Receives FDA Accelerated Approval as First Treatme... Ultragenyx’s GENGLYCOS Receives FDA Accelerated Approval as First Treatme... Read Post »
New Drug ApprovalRegeneron Wins FDA Approval for Pasatru to Reduce New Bone Formation in Adu... Regeneron Wins FDA Approval for Pasatru to Reduce New Bone Formation in Adu... Read Post »
Clinical TrialsArcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Arcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Read Post »
Health TidingsKaliVir Raises $14 Million to Advance VET3-TGI in Phase 1/1b Solid Tumor Tr... KaliVir Raises $14 Million to Advance VET3-TGI in Phase 1/1b Solid Tumor Tr... Read Post »
Health TidingsFDA Accepts Teva’s NDA for Ecopipam with Priority Review for Pediatric To... FDA Accepts Teva’s NDA for Ecopipam with Priority Review for Pediatric To... Read Post »
Health TidingsConsano Bio’s C-1101 Wins FDA Fast Track for Chronic Sciatica Consano Bio’s C-1101 Wins FDA Fast Track for Chronic Sciatica Read Post »
Health Tidings Mergers & AcquisitionsFulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Fulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Read Post »
Health TidingsKynexis Advances KYN-5356 Toward Registrational Development in Schizophreni... Kynexis Advances KYN-5356 Toward Registrational Development in Schizophreni... Read Post »
Health Tidings Mergers & AcquisitionsIDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC IDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC Read Post »
Clinical TrialsModerna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Moderna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Read Post »
ResearchCan Risdiplam Sustain Survival and Motor Function in Children with Type 1 S... Can Risdiplam Sustain Survival and Motor Function in Children with Type 1 S... Read Post »
Health TidingsAbcuro Raises $66M Series D for Ulviprubart IBM Phase 3 Trial Abcuro Raises $66M Series D for Ulviprubart IBM Phase 3 Trial Read Post »
Clinical TrialsCould Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Could Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Read Post »
Health Tidings Mergers & AcquisitionsChugai’s AID351 Anti-Dengue Antibody Licensed to GSK for Clinical Develop... Chugai’s AID351 Anti-Dengue Antibody Licensed to GSK for Clinical Develop... Read Post »
Health Tidings Mergers & AcquisitionsBioMarin to Acquire Alesta Therapeutics for $275 Million Upfront to Advance... BioMarin to Acquire Alesta Therapeutics for $275 Million Upfront to Advance... Read Post »
Clinical TrialsCan B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Can B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Read Post »
Health TidingsAVITA Medical Reports PermeaDerm Study Results Showing 70% Lower Treatment ... AVITA Medical Reports PermeaDerm Study Results Showing 70% Lower Treatment ... Read Post »
Clinical TrialsCan the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Can the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Read Post »
Health TidingsEvaxion Shifts Cancer Vaccine Focus to Glioblastoma With EVX-05 Following E... Evaxion Shifts Cancer Vaccine Focus to Glioblastoma With EVX-05 Following E... Read Post »
Health Tidings Mergers & AcquisitionsLEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... LEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... Read Post »
Health TidingsBlossomHill’s BH-30643 Gets FDA Fast Track Designation for EGFR C797S-Pos... BlossomHill’s BH-30643 Gets FDA Fast Track Designation for EGFR C797S-Pos... Read Post »
Clinical TrialsAvexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Avexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Read Post »
ResearchCan Dexamethasone Become a Noninvasive Option for Retinopathy of Prematurit... Can Dexamethasone Become a Noninvasive Option for Retinopathy of Prematurit... Read Post »
Health TidingsEli Lilly Joins $30 Million Series A to Advance Leal’s Schizophrenia and ... Eli Lilly Joins $30 Million Series A to Advance Leal’s Schizophrenia and ... Read Post »
Clinical TrialsInnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... InnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... Read Post »
Clinical TrialsKRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... KRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... Read Post »
GenericsBiocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled Auto... Biocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled Auto... Read Post »
Health TidingsFDA Grants Fast Track Designation to PIKTOR Plus Paclitaxel for Biomarker-S... FDA Grants Fast Track Designation to PIKTOR Plus Paclitaxel for Biomarker-S... Read Post »
Health TidingsFate Therapeutics Advances Fixed-Dose FT819 Into Phase 2 Lupus Nephritis Tr... Fate Therapeutics Advances Fixed-Dose FT819 Into Phase 2 Lupus Nephritis Tr... Read Post »
Mergers & AcquisitionsOmniAb and Lilly Launch New Ion Channel Discovery Collaboration Worth Up to... OmniAb and Lilly Launch New Ion Channel Discovery Collaboration Worth Up to... Read Post »
